TRANSCHEMPharmaceuticals
Transchem Ltd — PE Ratio & Valuation Analysis
₹162.65
+1.96%
Current P/E32.45xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E28.9x12.1% above avg
⚠️
2.1% Premium to Industry
TRANSCHEM P/E 32.45x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹4.27 | ₹183 | 42.9x |
| 2024 | ₹3.43 | ₹51 | 15x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Transchem Ltd Valuation
Transchem Ltd (TRANSCHEM) currently trades at 32.45x earnings. The Pharmaceuticals sector average PE is 31.77x. TRANSCHEM commands a premium, reflecting high growth expectations. Historically, TRANSCHEM has traded at an average PE of 28.9x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
6.75%
Dividend Yield
0.00%
More on Transchem Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.